These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 6588975

  • 1. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
    Hoogwerf BJ, Bantle JP, Kuba K, Frantz ID, Hunninghake DB.
    Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975
    [Abstract] [Full Text] [Related]

  • 2. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
    Lewis JE.
    Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156
    [Abstract] [Full Text] [Related]

  • 3. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA, Grundy SM.
    JAMA; 1984 May 04; 251(17):2241-6. PubMed ID: 6368883
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemia.
    Larsen ML, Illingworth DR, O'Malley JP.
    Atherosclerosis; 1994 Apr 04; 106(2):235-40. PubMed ID: 8060383
    [Abstract] [Full Text] [Related]

  • 5. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER, Sutherland WH, Temple Wa.
    N Z Med J; 1980 Nov 12; 92(671):345-9. PubMed ID: 6935550
    [Abstract] [Full Text] [Related]

  • 6. Clinical results with gemfibrozil.
    Pickering JE.
    Am J Cardiol; 1983 Aug 22; 52(4):39B-40B. PubMed ID: 6351579
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
    Hoogwerf BJ, Peters JR, Frantz ID, Hunninghake DB.
    Metabolism; 1985 Oct 22; 34(10):978-81. PubMed ID: 4046841
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies on hypoxic dyslipidaemia. Effect of lipid modulating drugs.
    Mälkönen M, Muona M, Manninen V.
    Acta Med Scand Suppl; 1982 Oct 22; 668():130-5. PubMed ID: 6963088
    [Abstract] [Full Text] [Related]

  • 12. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.
    Brook JG, Lavy A, Aviram M, Zinder O.
    Atherosclerosis; 1980 Aug 22; 36(4):461-9. PubMed ID: 7417365
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of gemfibrozil on serum lipids in man.
    Fenderson RW, Deutsch S, Menachemi E, Chin B, Samuel P.
    Angiology; 1982 Sep 22; 33(9):581-93. PubMed ID: 6751166
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
    Stuyt PM, Stalenhoef AF, Demacker PN, Van 't Laar A.
    Atherosclerosis; 1985 Apr 22; 55(1):51-62. PubMed ID: 3924065
    [Abstract] [Full Text] [Related]

  • 17. Fenofibrate therapy of hyperlipoproteinaemia. A dose-response study and a comparison with clofibrate.
    Rössner S, Orö L.
    Atherosclerosis; 1981 Apr 22; 38(3-4):273-82. PubMed ID: 7225166
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P, Weisweiler P, Neureuther G.
    Artery; 1979 Feb 22; 5(2):117-24. PubMed ID: 231950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.